DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Buphenyl Therapy for Byler's Disease

Information source: University of Pittsburgh
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Byler Disease

Intervention: Buphenyl (Drug)

Phase: N/A

Status: No longer available

Sponsored by: University of Pittsburgh

Summary

This is a single patient compassionate use protocol to determine whether Buphenyl (4-phenylbutyrate) will improve the poor bile flow associated with Byler Disease.

Clinical Details

Official title: Compassionate Use of BuphenylŪ in the Treatment of Byler's Disease

Study design: N/A

Eligibility

Minimum age: 1 Year. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Byler Disease

- Cholestasis unresponsive to pharmacologic therapy

Exclusion Criteria:

- Allergy/Hypersensitivity to Buphenyl

Locations and Contacts

Additional Information


Last updated: February 4, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017